| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
BioHarvest Sciences Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.26 |
| 52 Week High | CA$0.30 |
| 52 Week Low | CA$0.14 |
| Beta | 1.46 |
| 1 Month Change | -7.27% |
| 3 Month Change | 18.60% |
| 1 Year Change | 6.25% |
| 3 Year Change | -33.77% |
| 5 Year Change | n/a |
| Change since IPO | 70.00% |
Recent News & Updates
BioHarvest Sciences Inc.'s (CSE:BHSC) P/S Is On The Mark
Mar 17
Investors Interested In BioHarvest Sciences Inc.'s (CSE:BHSC) Revenues
Dec 01Recent updates
BioHarvest Sciences Inc.'s (CSE:BHSC) P/S Is On The Mark
Mar 17Investors Interested In BioHarvest Sciences Inc.'s (CSE:BHSC) Revenues
Dec 01Don't Ignore The Fact That This Insider Just Sold Some Shares In BioHarvest Sciences Inc. (CSE:BHSC)
Jan 17How Much Of BioHarvest Sciences Inc. (CSE:BHSC) Do Insiders Own?
Jan 10
Shareholder Returns
| BHSC | CA Personal Products | CA Market | |
|---|---|---|---|
| 7D | 0% | -1.3% | 0.7% |
| 1Y | 6.3% | -15.1% | 4.9% |
Return vs Industry: BHSC exceeded the Canadian Personal Products industry which returned -11.8% over the past year.
Return vs Market: BHSC matched the Canadian Market which returned 5.5% over the past year.
Price Volatility
| BHSC volatility | |
|---|---|
| BHSC Average Weekly Movement | 8.8% |
| Personal Products Industry Average Movement | 8.5% |
| Market Average Movement | 9.0% |
| 10% most volatile stocks in CA Market | 18.1% |
| 10% least volatile stocks in CA Market | 3.0% |
Stable Share Price: BHSC has not had significant price volatility in the past 3 months.
Volatility Over Time: BHSC's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Ilan Sobel | www.bioharvest.com |
BioHarvest Sciences Inc. operates as a biotechnology company. The company develops botanical synthesis platform technology to grow the ingredients inherent in various fruits and plants without the need to grow the plant itself. The company is leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions in nutraceuticals and pharmaceuticals verticals.
BioHarvest Sciences Inc. Fundamentals Summary
| BHSC fundamental statistics | |
|---|---|
| Market cap | CA$146.59m |
| Earnings (TTM) | -CA$11.11m |
| Revenue (TTM) | CA$14.48m |
10.1x
P/S Ratio-13.2x
P/E RatioIs BHSC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BHSC income statement (TTM) | |
|---|---|
| Revenue | US$10.60m |
| Cost of Revenue | US$6.59m |
| Gross Profit | US$4.01m |
| Other Expenses | US$12.14m |
| Earnings | -US$8.13m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.014 |
| Gross Margin | 37.81% |
| Net Profit Margin | -76.77% |
| Debt/Equity Ratio | -128.9% |
How did BHSC perform over the long term?
See historical performance and comparison